Comprehensive Review of the Application of Aptamer-Based Point-Of-Care Sensors for Therapeutic Drug Monitoring
Aptasensors hold a transformative potential for advancing point-of-care TDM, offering a pathway for personalized treatment optimization. Future efforts should prioritize rigorous clinical validation and improved stability in actual biological samples to fully realize their role in precision medicine.
Authors
- Qiaoqiao Li (ORCID: https://orcid.org/0000-0001-9710-7135)
- Yang Liu (ORCID: https://orcid.org/0000-0002-5939-0846)
- Tiantian Tang (ORCID: https://orcid.org/0000-0002-0516-6363)
- Wanyi Chen (ORCID: https://orcid.org/0000-0002-8675-6567)
- Yuxin Huang (ORCID: https://orcid.org/0000-0003-2279-4588)
- Zhenya Liu (ORCID: https://orcid.org/0000-0002-3487-5070)
- Lixian Li (ORCID: https://orcid.org/0000-0003-1931-8281)
- Chunjie Shi
- Weijun Qin (ORCID: https://orcid.org/0009-0000-4794-3565)
- Yuanqiang Wang (ORCID: https://orcid.org/0000-0002-4646-4375)
Institutions
- Chongqing University (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing University of Technology (CN)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1097/ftd.0000000000001383
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00